More Business Wire
View Older Stories View Newer Stories-
ATCC Announces Award from NIAID to Support Preclinical Models of Infectious Diseases
-
Survey: Nearly 1 in 4 of All Parents and Half of Gen X Parents Worry Their Kids Will Be Financially Dependent on Them in Adulthood
-
Monte Carlo Appoints Former Stack Overflow Exec Tim Miller as Chief Revenue Officer
-
TD Bank Announces Andy Bregenzer and Jill Gateman as Co-Heads of U.S. Commercial Banking
-
Marco Di Giacomo Joins Remote as Chief Marketing Officer
-
Alnylam to Webcast TTR Investor Day
-
AtoB Partners with Sunoco to Expand Nationwide Network and Deliver Enhanced Fuel Discounts
-
As Spectrum Center Prepares to Reopen, Arena Announces Addition of Evolv Technology at Entrances
-
Creative Growth Teams Up with John McNeil Studio to Become an Undeniable Voice for Artists with Disabilities
-
ChargePoint Highlights Trends and Technologies Which Will Propel the Charging Industry’s Future Growth
-
Easterly Clear Ocean Announces Sale of Three Chemical Tankers and Capitalizes on Maritime Market Opportunity
-
Bot Auto Secures $20M in Pre-A Funding to Commercially Deploy Autonomous Trucking
-
858 Therapeutics Announces $50 Million Series B Financing
-
HilltopSecurities Public Entity Survey Results Now Available
-
Growth Equity Firm Edison Partners Leads $20M Investment in K1x
-
Rubrik and Pure Storage Partner to Offer Complete Cyber Resilience, Protecting Data and Minimizing Downtime
-
Wallarm Named to IT Harvest’s Cyber150 List of Top Cybersecurity Companies
-
Cardurion Pharmaceuticals Appoints Ron Renaud to Board of Directors
-
Macy’s and Toys“R”Us® Announce Geoffrey’s Hot Toy List for the 2024 Holiday Season
-
Organic Infant Formula Company Bobbie Expands Retail Footprint and Availability With Launch at Whole Foods Markets Nationwide
-
Redfin Reports Buyers Are Coming Back: Mortgage Demand Shoots Up, Home Tours Hit Highest Level Since May
-
NICE Actimize Wins 2024 FTF News Technology Innovation Award for Best Operational Risk Management Solution
-
Fidelity Investments Canada Returns to Cboe Canada For Launch of New Equity Premium Yield ETF
-
Siemens Energy Standardizes Predictive Maintenance Operations on InfluxDB
-
Commerce Bank Selects FIS to Unlock Advanced Loyalty Solutions for Customers
-
Hallmark Unveils Strategic Advisory Board and New Center of Excellence to Drive Innovation in Healthcare Workforce Management
-
Viz.ai Announces New Clinical Data Demonstrating Fewer Futile Transfers and Substantial Cost Savings in Stroke
-
Coca-Cola Bottlers’ Sales and Services Refreshes the Customer and Employee Experience with Genesys
-
CitiusTech Partners With Novant Health to Support Enterprise Decision Intelligence, Drive Outcomes
-
1&1 Versatel modernizes fiber optic network with Adtran FSP 3000 open optical transport technology
-
Gabriel Simkin Joins CV Advisors as Associate Portfolio Manager and Investment Committee Observer
-
Georgia Southern University Names Second Annual Yamaha Rightwaters™ Conservation Scholarship Recipient
-
Becker Partners With CPA Bermuda to Offer U.S. CPA Exam Review for Bermudians Who Want to Pursue CPA Designation
-
The National Payroll Institute Issues a Financial Wellness Wake-Up Call for Canada
-
Endava Releases 2024 Sustainability Report and Announces SBTi Targets
-
TotalEnergies: Norway: Northern Lights Facilities Completed and Ready to Store CO2
-
DocGo Appoints Eiwe Lingefors as New Chief Information Officer
-
Wiley Announces Quarterly Dividend
-
Jabil Posts Fourth Quarter and Fiscal Year 2024 Results
-
Baxter Launches Next Generation of The Vest System for Airway Clearance
-
Dynacor Group Declares October 2024 Dividend
-
Kainos Capital Promotes David Gassko and Jeff Moredock to Partner
-
Real August Agent Survey Reveals Stability Amid NAR Settlement-Related Practice Changes
-
Electra Commercial Team to Attend LME Week
-
Capstan Therapeutics to Present Preclinical Data on Lead In Vivo Chimeric Antigen Receptor (CAR)-T Candidate, CPTX2309, at American College of Rheumatology (ACR) Convergence 2024
-
AI Robot Becomes Board Advisor at Realbotix
-
Vertex Highlights First Oral Presentation of Phase 3 Clinical Data of the Vanza Triple and New Data on Long-Term Impact of TRIKAFTA® at the North American Cystic Fibrosis Conference
-
Bayer Submits Supplemental New Drug Application to U.S. FDA Seeking Expanded Indication for NUBEQA® (darolutamide) in Metastatic Hormone-Sensitive Prostate Cancer
-
Zeta Live 2024: Zeta Global Launches AI-Powered Intelligent Mobile Solution and Expands Agents Lineup
-
Stevanato Group, Gerresheimer and SCHOTT Pharma, Announce Strategic Industry “Alliance for RTU”
